Nucleic Acid Cargo Protection and Delivery Systems

Nucleic acid cargo protection and delivery systems are specialized carriers designed to protect and transport nucleic acid therapeutics (DNA, RNA, siRNA, mRNA) to target sites within cells, overcoming numerous biological barriers. These systems are not therapeutic targets themselves but crucial delivery mechanisms for genetic material in gene therapy applications. They include non-viral approaches such as lipid-based carriers (e.g., lipid nanoparticles), polymeric carriers, and inorganic nanoparticles, as well as specialized carriers like cell-penetrating peptides. Their primary function involves protecting nucleic acids from degradation in circulation, enabling cell membrane penetration, facilitating endosomal escape, and, for DNA, promoting nuclear translocation. Recent advancements include cargo-selective systems and pH-responsive ionizable lipid nanoparticles. These systems are vital for clinical applications in cancer gene therapy, genetic disorders, vaccine development (e.g., mRNA COVID-19 vaccines), and protein replacement therapies. Key challenges include optimizing efficacy-safety balance, reducing toxicity, and improving targeting specificity.

Other names

Nucleic acid delivery systemsGene delivery systemsRNA delivery systemsDNA delivery systemsGenetic material delivery systemsDrug delivery vehicles for nucleic acids

Nucleic acid delivery systems function by protecting nucleic acids from enzymatic degradation and sequestration in circulation, facilitating cell membrane penetration, and enabling endosomal escape through mechanisms like pH-responsiveness, proton sponge effect, or membrane disruption. For DNA, they also promote nuclear translocation. These systems utilize passive targeting via the Enhanced Permeability and Retention (EPR) effect or active targeting through surface modification with specific ligands to enhance delivery to desired sites.